DCRI Think Tanks Demonstrate What Is Possible

​​

DCRI Think Tanks Demonstrate What Is Possible

Tackling today’s healthcare challenges requires collaboration from every stakeholder, including patients, academic investigators, site investigators, regulatory agencies, pharmaceutical and device industry leaders, payers, technology companies and more.

DCRI Think Tanks demonstrate what is possible when you bring smart people together to tackle the biggest challenges in clinical research. From cardiovascular diabetes to the Pediatric Rule to the Modern Data Monitoring Committee, these meetings are about creating pathways to useful, focused discussions across the healthcare continuum and then moving consensus to action.

Our mission—to address the most critical gaps in clinical research by convening leaders across the healthcare industry to map the way forward in designing, conducting, and implementing high-quality, evidence-based research.

ThinkTk_byNumbers
Medicine doctor working with modern computer

MEETING OBJECTIVES

  1. Review value-added implications for new technological advances that enhance clinical trial efficiency and streamline trial conduct
  2. Discuss the emerging perspectives of clinical trial stakeholders on technology infiltration
  3. Delineate innovative trial designs and options facilitated by technological advances and potential barriers to implementation of innovative trials
  4. Determine the optimal framework for regulatory oversight and partnerships needed to guide the role of technology in changing clinical research paradigms

October 3-4, 2018

Technology-Enabled Clinical Trials—Innovations in Trial Design and Conduct

The “Technology-Enabled Clinical Trials” think tank meeting convened by Duke Clinical Research Institute brought together diverse stakeholders and perspectives to address the emerging perspectives on the evolution of technological solutions that support clinical trials. At this meeting, our aim was to foster the collaborative partnerships needed to ensure the proper oversight and implementation of these technological advances that are positioned to accelerate the assessment of promising new therapies.

Contact Carolyn Moore Arias with questions.

Meeting Co-Directors

Eric Peterson
Eric Peterson

Matthew Roe

DCRI Think Tanks Publications

Heart Failure Preserved Ejection Fraction

Meeting date: June 7-8, 2017

Advancing Care and Clinical Trials through Digital Health

Meeting date: December 5-6, 2016

Issues in Pediatric Cardiovascular Drug Development

Meeting date: September 8-9, 2016

Leveraging E.H.R. for Clinical Research Now!

Meeting date: February 18-19, 2016

Meeting and Publication Archive

Previous DCRI Think Tanks meetings with their associated publications are archived in 5-year increments.

Partnership

DCRI Think Tanks is partnered with the CardioVascular Clinical Trialists Forum (CVCT)—a unique experts-only forum aimed at discussing important and timely CV trials and trial science issues (design, methodology, interpretation, approval and implementation). Their emphasis on interaction among highly knowledgeable global experts from multiple backgrounds, including academy, industry R&D, regulatory agencies, major journal editors, NHLBI, payers (CMS, HTA organizations) and patient representatives makes them a key DCRI Think Tanks contributor.

DCRI Think Tank faculty lead Dr.Matthew Roe and Fred Cobb Distinguished Professor of Medicine Dr.Eric Peterson will be chairing a joint CVCT-Duke Think Tank session with Dr. Martin Cowie at the upcoming annual 2018 CVCT meeting titled “eSolutions – Big Data – Smart Data and How These May Help with Clinical Evidence Generation” on Friday, November 30 at 2:00pm.

CVCT Forum

Patient-Reported Outcome Measures

Meeting date: July 25-26, 2018

Key questions addressed:

  1. What does it mean to justify the use of a PRO in a regulated trial?
  2. How comfortable are key stakeholders in tolerating different degrees of uncertainty about the validity of a PRO measure for different contexts of use?
  3. What types of studies are best suited to justify the use of PRO measures in different contexts?
Co-Director
Adrian Hernandez

Adrian Hernandez, MD, MHS
Vice Dean for Clinical Research
Duke University School of Medicine
DCRI Faculty
Professor of Medicine, Cardiology

 

Co-Director

Kevin Weinfurt, PhD
Professor and Vice Chair for Research
Department of Population Health Sciences
Duke University School of Medicine
Co-Director, Duke Center for Health Measurement
DCRI Faculty

 

Significant Contributor
Professor and Director of Center for Health Measurement
Population Health Sciences
Duke University School of Medicine

 

Manuscript Lead
Assistant Professor
Department of Population Health Sciences
Duke University School of Medicine

 

Cardiovascular Outcomes and Diabetes Drugs: Lessons Learned and Path Forward

DCRI faculty joined a DCRI Research Forum panel on March 6, 2018 to share their perspectives on Cardiovascular Outcomes and Diabetes Drugs after attending a think tank meeting on the same topic.

Leadership


Matthew T. Roe, MD, MHS
DCRI Think Tanks Faculty Lead
Senior Investigator, Duke Clinical Research Institute
Professor of Medicine, Duke University Medical Center


Carolyn Moore Arias, MPH
Associate Director, DCRI Think Tanks
Carolyn.Arias@duke.edu

Connect with Us

The DCRI Think Tank program welcomes suggestions and ideas for future think tank meetings.

Contact Carolyn Moore Arias or Matthew Roe to share your idea or to get involved, or follow us on Twitter at @DCRINews. Look for the #DCRIThinkTank hashtag.

 

 

In Support of and Collaboration with: